全文获取类型
收费全文 | 2473篇 |
免费 | 243篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 116篇 |
妇产科学 | 39篇 |
基础医学 | 321篇 |
口腔科学 | 45篇 |
临床医学 | 245篇 |
内科学 | 518篇 |
皮肤病学 | 33篇 |
神经病学 | 153篇 |
特种医学 | 165篇 |
外国民族医学 | 1篇 |
外科学 | 471篇 |
综合类 | 63篇 |
一般理论 | 1篇 |
预防医学 | 193篇 |
眼科学 | 87篇 |
药学 | 171篇 |
1篇 | |
中国医学 | 7篇 |
肿瘤学 | 86篇 |
出版年
2021年 | 33篇 |
2018年 | 27篇 |
2017年 | 31篇 |
2016年 | 24篇 |
2015年 | 37篇 |
2014年 | 55篇 |
2013年 | 60篇 |
2012年 | 85篇 |
2011年 | 89篇 |
2010年 | 65篇 |
2009年 | 67篇 |
2008年 | 81篇 |
2007年 | 96篇 |
2006年 | 99篇 |
2005年 | 69篇 |
2004年 | 72篇 |
2003年 | 68篇 |
2002年 | 77篇 |
2001年 | 77篇 |
2000年 | 84篇 |
1999年 | 64篇 |
1998年 | 46篇 |
1997年 | 46篇 |
1996年 | 72篇 |
1995年 | 49篇 |
1994年 | 51篇 |
1993年 | 33篇 |
1992年 | 39篇 |
1991年 | 62篇 |
1990年 | 53篇 |
1989年 | 75篇 |
1988年 | 61篇 |
1987年 | 50篇 |
1986年 | 68篇 |
1985年 | 58篇 |
1984年 | 51篇 |
1983年 | 51篇 |
1982年 | 36篇 |
1981年 | 28篇 |
1980年 | 23篇 |
1979年 | 37篇 |
1978年 | 29篇 |
1977年 | 36篇 |
1976年 | 23篇 |
1975年 | 29篇 |
1974年 | 20篇 |
1973年 | 37篇 |
1970年 | 20篇 |
1968年 | 19篇 |
1967年 | 19篇 |
排序方式: 共有2729条查询结果,搜索用时 15 毫秒
1.
2.
3.
Ketai LH; Williamson MR; Telepak RJ; Levy H; Koster FT; Nolte KB; Allen SE 《Radiology》1994,191(3):665
4.
L Bullock J F Fitzgerald M R Glick R B Parks J G Schnabel B G Hancock 《American journal of hospital pharmacy》1989,46(11):2321-2325
The stability of famotidine in total parenteral nutrient (TPN) solutions and the concentrations of amino acids in the presence of famotidine were determined. Two famotidine concentrations (20 mg/L and 40 mg/L) and two amino acid concentrations (20 g/L and 42.5 g/L) were studied under the following storage conditions: refrigerated for 24 hours and then kept at room temperature (20-22 degrees C) for 24 hours, at room temperature for 48 hours, or refrigerated for seven days. Control TPN solutions were studied under the same storage conditions. TPN solutions also contained dextrose 25%, electrolytes, trace elements, and vitamins. Famotidine concentration was determined at 0, 24, and 48 hours and at seven days by high-performance liquid chromatography. Amino acid concentration was determined in the TPN solutions containing 42.5 g/L of amino acids without famotidine and with famotidine 40 mg/L under both 48-hour storage conditions. At 24 hours, all solutions retained at least 95% of the initial famotidine concentration. Seven of the eight famotidine solutions retained more than 95% of the initial famotidine concentration at 48 hours. All samples refrigerated for seven days retained more than 95% of the initial famotidine concentration. The concentration of amino acids in TPN solutions containing 42.5 g/L of amino acids was not affected by the addition of famotidine 40 mg/L under either 48-hour storage condition. Famotidine in concentrations of 20 mg/L and 40 mg/L is stable under the studied 48-hour storage conditions in TPN solutions containing amino acid concentrations of either 20 g/L or 42.5 g/L.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
5.
6.
Braffman BH; Coleman BG; Ramchandani P; Arger PH; Nodine CF; Dinsmore BJ; Louie A; Betsch SE 《Radiology》1994,190(3):797
7.
Kinnison ML; Perler BA; Kaufman SL; Mitchell SE; Kadir S; Williams GM; White RI Jr 《Radiology》1986,160(3):727-730
In situ saphenous vein grafts are being used with increasing frequency for bypass procedures involving the femoral and popliteal arteries. Complications of these procedures include anastomotic stenoses and persistent arteriovenous fistulae that may result in failure of the graft. Balloon angioplasty and embolotherapy with detachable balloons were employed successfully in three or four recent cases of patients with complications from in situ grafts. Tailored angiography is essential for evaluating in situ grafts, and interventional techniques are extremely useful for managing complications. 相似文献
8.
Buspirone treatment of aggression and anxiety in mentally retarded patients: a multiple-baseline, placebo lead-in study 总被引:2,自引:0,他引:2
Buspirone, a new anxiolytic agent, was used in a multiple-baseline, placebo lead-in study for the treatment of aggression and anxiety in six mentally retarded adult patients. The findings demonstrate buspirone's effectiveness in reducing aggression and anxiety in a mentally retarded group of subjects without causing deleterious cognitive side effects. The authors review a body of literature on animal and human subjects where buspirone was used in the treatment of aggression and other mental disorders. Unlike neuroleptics and benzodiazepines, buspirone does not cause sedation which can compromise adaptive and intellectual capacities and thus reduce the patient's potential to benefit from training programs. 相似文献
9.
Carlton W. Parks 《Archives of sexual behavior》2002,31(6):553-554
10.